Guys, the more I think about this chart and this company, the more I can't imagine what could cause it to plummet in the intermediate term. Say 1 year timeframe. It's well capitalised with wind at it's sales.
I'm not experienced with biotech investing, but I am truly an investor in this. I've held a core position for a very long time, almost on a hunch and have basically doubled it post FDA approval.
Does anyone have any guidance as to the possible risks that could blow this thing up? Or are we just firmly planted in a stage 2 uptrend with maybe a basing period here and there for the foreseeable future..?
Could weak sales figures sink the ship? What are the hazards that could be ahead?
Not trying to drum up and doom, I just want to know for my own learning and understanding. I'll even take book recommendations about biotech if anyone has any. Thanks.
BOT - Anything but charting, page-9445
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.0¢ | $1.603M | 4.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 378157 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 98000 | 5 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |